Enhanced Vitals Monitoring for Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether enhanced monitoring devices can improve recovery after certain surgeries. It focuses on patients undergoing medium- to high-risk vascular or abdominal surgeries to determine if more frequent vital sign checks can increase the number of days spent at home in the first month post-surgery. Participants will use special devices to monitor their vitals both in the hospital and at home. This trial may suit those having these surgeries at St. Paul’s Hospital, who expect to stay in the hospital for at least two days and can use the devices at home. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance post-surgical recovery for future patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this enhanced vitals monitoring is safe for surgical patients?
Research shows that using wearable devices to closely monitor vital signs can make surgery recovery safer. Studies have found that continuous tracking of health signals helps reduce complications for patients. This method monitors important health indicators and quickly alerts doctors if something is wrong.
Health Canada has approved the devices used for this monitoring, confirming they meet safety standards. Patients in earlier studies used these devices without any serious side effects. Overall, evidence suggests that this type of monitoring is a safe way to potentially improve recovery after surgery.12345Why are researchers excited about this trial?
Researchers are excited about Enhanced Vitals Monitoring because it offers a more comprehensive way to track patients' health after surgery compared to standard care. Unlike the usual monitoring done only in hospitals, this method uses Health Canada-approved devices for continuous monitoring at home, three times a day, for up to 30 days post-surgery. This enhanced monitoring can quickly alert medical teams if vital signs reach critical levels, potentially leading to faster interventions and better patient outcomes.
What evidence suggests that enhanced vitals monitoring is effective for post-operative management?
In this trial, participants will join one of two groups. The Enhanced Vitals Monitoring group will receive enhanced monitoring using Health Canada-approved devices in the hospital, followed by thrice-daily monitoring at home for up to 30 days postoperatively. Previous studies have shown that continuous vital sign tracking in a hospital improved certain health measures and reduced complications for surgery patients. Research indicates that advanced monitoring devices can detect potential issues early, leading to better recovery after surgery. For patients healing from surgery, continuous monitoring has enhanced safety and quality of care. Early findings suggest that improved monitoring can help maintain patient health and may shorten hospital stays, potentially allowing more time at home in the first month after surgery.23467
Who Is on the Research Team?
Janny Ke, MD
Principal Investigator
University of British Columbia
Are You a Good Fit for This Trial?
This trial is for adults in British Columbia, Canada who are having medium- to high-risk vascular or abdominal surgery at St. Paul's Hospital and expect to stay there for at least 48 hours. They should be able to read and speak English (or have a caregiver who can) and live in an area with Bell cellular network coverage.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Monitoring
Participants undergo major abdominal or vascular surgery with continuous monitoring of vital signs in-hospital
Enhanced Monitoring
Participants in the intervention group receive enhanced monitoring using devices in-hospital and thrice-daily at home for up to 30 days postoperatively
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a follow-up phone call and questionnaire
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Vitals Monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Cloud DX Inc.
Industry Sponsor
Excelar
Collaborator
3D Bridge Solutions
Collaborator
Providence Health & Services
Collaborator
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc
Simon Fraser University
Collaborator
Providence Health Care Ventures
Collaborator